• Exchange: NYSE MKT LLC
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Equipment

Navidea Biopharmaceuticals Inc

+ Add to Watchlist

NAVB:US

1.3000 USD 0.0400 3.17%

As of 09:58:36 ET on 09/23/2014.

Snapshot for Navidea Biopharmaceuticals Inc (NAVB)

Open: 1.2800 Day's Range: 1.2800 - 1.3300 Volume: 73,766
Previous Close: 1.2600 52wk Range: 1.1100 - 2.8900 1-Yr Rtn: -53.85%

Stock Chart for NAVB

No chart data available.
  • NAVB:US 1.2900
  • 1D
  • 1M
  • 1Y
1.2600
Interactive NAVB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for NAVB

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.3284
Est. EPS (USD) (12/2014) -0.2730
Est. PEG Ratio -
Market Cap (M USD) 189.80
Shares Outstanding (M) 150.64
30 Day Average Volume 538,632
Price/Book (mrq) -
Price/Sale (ttm) 67.1487
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for NAVB

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for NAVB

Navidea Biopharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of precision radiopharmaceutical diagnostics for diseases such as cancer.

Thomas H Tulip "Thom"President/Chief Business OfcrMichael M GoldbergInterim CEO
Brent L LarsonExec VP/CFO/Treasurer/SecyCornelia B ReiningerSenior VP/Chief Medical Officer
More Company Profile & Key Executives for NAVB

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil